Page last updated: 2024-10-20

taurine and Neutropenia

taurine has been researched along with Neutropenia in 2 studies

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research Excerpts

ExcerptRelevanceReference
" Patients with haematological cancer who are expected to develop prolonged neutropenia (> 7 days) and who have a non-tunnelled CVC implanted will be randomised to receive prophylactic taurolidine-citrate-heparin solution using a lock technique (study group) or heparin alone (placebo group)."5.27Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT). ( Aguilar-Guisado, M; Arnan, M; Berbel, D; Carratalà, J; Cisneros-Herreros, JM; Encuentra, M; Gudiol, C; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Royo-Cebrecos, C, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gudiol, C2
Arnan, M2
Aguilar-Guisado, M2
Royo-Cebrecos, C2
Sánchez-Ortega, I1
Montero, I2
Martín-Gandul, C2
Laporte-Amargós, J1
Albasanz-Puig, A1
Nicolae, S2
Perayre, M2
Berbel, D2
Tebe, C1
Riera, J1
Sureda, A1
Cisneros, JM1
Carratalà, J2
Encuentra, M1
Cisneros-Herreros, JM1

Trials

2 trials available for taurine and Neutropenia

ArticleYear
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
    Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2

    Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citrates; Do

2020
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Trials, 2018, May-02, Volume: 19, Issue:1

    Topics: Anti-Infective Agents; Antineoplastic Agents; Catheter-Related Infections; Catheterization, Central

2018